News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
327,458 Results
Type
Article (19575)
Company Profile (139)
Press Release (307744)
Section
Business (105174)
Career Advice (866)
Deals (18489)
Drug Delivery (90)
Drug Development (50618)
Employer Resources (79)
FDA (7628)
Job Trends (7715)
News (185467)
Policy (17289)
Tag
Academia (726)
Alliances (27686)
Alzheimer's disease (560)
Approvals (7596)
Artificial intelligence (81)
Bankruptcy (170)
Best Places to Work (5503)
Biosimilars (67)
Biotechnology (62)
Cancer (545)
Cardiovascular disease (60)
Career advice (704)
Cell therapy (83)
Clinical research (41720)
Collaboration (213)
Compensation (69)
COVID-19 (1073)
C-suite (60)
Data (616)
Diabetes (94)
Diagnostics (1716)
Drug pricing (91)
Earnings (38280)
Employer resources (73)
Events (47564)
Executive appointments (199)
FDA (7887)
Funding (155)
Gene therapy (87)
GLP-1 (483)
Government (1796)
Healthcare (5853)
Infectious disease (1121)
Inflammatory bowel disease (67)
Interviews (114)
IPO (7289)
Job creations (2429)
Job search strategy (645)
Layoffs (252)
Legal (4078)
Lung cancer (96)
Manufacturing (128)
Medical device (1946)
Medtech (1949)
Mergers & acquisitions (11237)
Metabolic disorders (325)
Neuroscience (724)
NextGen Class of 2024 (2347)
Non-profit (901)
Northern California (664)
Obesity (209)
Opinion (174)
Patents (70)
People (32893)
Pharmaceutical (75)
Phase I (12997)
Phase II (17660)
Phase III (14220)
Pipeline (281)
Podcasts (56)
Policy (70)
Postmarket research (1609)
Preclinical (4562)
Radiopharmaceuticals (156)
Rare diseases (137)
Real estate (3164)
Regulatory (12112)
Research institute (815)
Resumes & cover letters (138)
Southern California (614)
Startups (2005)
United States (6094)
Vaccines (210)
Weight loss (183)
Date
Today (62)
Last 7 days (399)
Last 30 days (1854)
Last 365 days (17909)
2024 (16381)
2023 (19635)
2022 (25865)
2021 (26639)
2020 (24871)
2019 (20059)
2018 (15589)
2017 (17253)
2016 (16202)
2015 (18801)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
Location
Africa (406)
Asia (24449)
Australia (3146)
California (1493)
Canada (742)
China (145)
Colorado (63)
Connecticut (60)
Europe (50449)
Florida (210)
Illinois (146)
Indiana (115)
Japan (56)
Maryland (228)
Massachusetts (1264)
Minnesota (87)
New Jersey (576)
New York (436)
North Carolina (357)
Northern California (664)
Ohio (63)
Pennsylvania (368)
South America (603)
Southern California (614)
Texas (193)
Washington State (144)
327,458 Results for "acasti pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Acasti Pharma to Attend BIO International Convention 2024
Acasti Pharma Inc. announced that the Company will be participating in the BIO International Convention taking place at the San Diego Convention Center from June 3-6, 2024.
May 28, 2024
·
6 min read
Business
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
Acasti Pharma Inc. today announced financial results and business highlights for the year ended March 31, 2024.
June 21, 2024
·
11 min read
Drug Development
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
Acasti Pharma Inc. announced that the Company’s pivotal Phase 3 STRIVE-ON safety trial has exceeded the 50% enrollment milestone.
June 27, 2024
·
6 min read
Press Releases
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
October 28, 2024
·
8 min read
Press Releases
Acasti to Present at the Life Sciences Investor Forum
September 12, 2024
·
7 min read
Business
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (aSAH), today announced financial results and business highlights for the quarter ended December 31, 2023.
February 12, 2024
·
10 min read
Business
Acasti Pharma Reports Fiscal Year 2023 Operational Results
Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST) today announced financial and operational results for the fiscal year ended March 31, 2023.
June 23, 2023
·
10 min read
Pharm Country
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON TrialAccepted for Presentation at the 2024 International Stroke Conference
Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company) today announced that a poster outlining its pivotal Phase 3 STRIVE-ON safety trial (the STRIVE-ON trial–NCT05995405) has been accepted for presentation at the 2024 International Stroke Conference, to be held February 7-9, 2024 in Phoenix, AZ.
February 1, 2024
·
6 min read
Deals
Acasti Pharma Announces 1-for-6 Reverse Stock Split
Acasti Pharma Inc. today announced that the Company will effect a 1-for-6 reverse split of its issued and outstanding common shares.
July 7, 2023
·
5 min read
Pharm Country
Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024
Acasti Pharma Inc. today announced that Chief Executive Officer Prashant Kohli will participate in the following investor and industry networking events in San Francisco, California during the week of January 7-12, 2024.
December 13, 2023
·
5 min read
1 of 32,746
Next
